Pneumococcal Disease: Recommended vaccinations
Back to search
Export to spreadsheet
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 		 Vaccination not funded by the National Health system
 		 Mandatory vaccination
MonthsYears
2345610111213141518232356121819506061646575≥ 76
Austria
PCV
PCV
PCV
PCV1
PCV
PCV
PCV+PPSV232
Belgium
PCV13
PCV13
PCV13
PCV13+PPSV233
PCV13+PPSV234
Bulgaria
PCV
PCV
PCV5
PCV13+PPSV236
Croatia
PCV7
PCV7
PCV7
Cyprus
PCV
PCV
PCV8
PPSV239
PPSV2310
Czech Republic
PCV11
PCV11
PCV11
PCV13+PPSV2312
PCV13+PPSV2313
Denmark
PCV13
PCV13
PCV13
PPSV2314
Estonia
PCV13+PPSV2315
Finland
PCV10
PCV10
PCV10
PCV13+PPSV2316
France
PCV
PCV
PCV
PCV13+PPSV2317
Germany
PCV
PCV
PCV
PCV18
PPSV2319
Greece
PCV13
PCV13
PCV13
PCV13
PCV13
PCV13+PPSV2320
PCV13+PPSV23
PCV13+PPSV23
Hungary
PCV13
PCV13
PCV13
PCV13+PPSV23
Iceland
PCV10
PCV10
PCV10
PPSV2321
Ireland
PCV
PCV
PCV
PPSV2322
Italy
PCV
PCV
PCV
PCV13+PPSV2323
Latvia
PCV
PCV
PCV
Liechtenstein
PCV13
PCV13
PCV13
Lithuania
PCV
PCV
PCV24
Luxembourg
PCV
PCV
PCV
PCV
PPSV2325
PCV13+PPSV2325
Malta
PCV10
PCV10
PCV10
Netherlands
PCV
PCV
PCV
PPSV2326
Norway
PCV13
PCV13
PCV13
PPSV2327
Poland
PCV
PCV
PCV
PCV
Portugal
PCV1328
PCV13
PCV13
Romania
PCV1329
PCV1329
PCV1329
Slovakia
PCV
PCV
PCV
PCV30
Slovenia
PCV13
PCV13
PCV13
PCV13+PPSV2331
Spain
PCV32
PCV32
PCV32
PPSV23 / PCV+PPSV2333
PPSV2332
Sweden
PCV
PCV
PCV
PPSV2334

Footnotes:

  1. Minimum interval of 6 month after second dose
  2. PCV13 and PPV23 one year apart.
  3. for additional information please refer to the relevant recommendations for pneumococcal vaccination (dated 2020: https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/css_9562_fiche_vaccination_antipneumococcique_vweb.pdf) and specifically for the vaccination of immunocompromised and chronically ill children and adults: https://www.health.belgium.be/en/advisory-report-9158-ic-patients-and-vaccination
  4. PCV13 and PPV23 one year apart. https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/css_9562_fiche_vaccination_antipneumococcique_vweb.pdf
  5. Not earlier than 6 months after the previous dose
  6. PCV13 is given starting from 50 years. The scheme is completed with PPSV23 in 65 years and older
  7. Introduced in 2019
  8. catch-up possible until 6 years if previous recommended doses were missed
  9. vaccines only given on specific indications
  10. No revaccination recommended.
  11. Recommendation only, the vaccination is covered by the health insurance
  12. Any PCV or PPSV23. Vaccination is especially recommended for people with chronic lung disease (includes moderate and severe bronchial asthma), with long-term medical treatment; persons with heart disease and/or large vessels with long-term systemic medical treatment, such as hypertension; people with chronic kidney and liver disease; patients with diabetes mellitus; patients with an immune disorder system (eg patients with immunosuppressive treatment (steroids, HIV infections, etc.) and asplenia / hyposplenia; patients with anticancer treatment; patients before / after solid organ and / or bone marrow transplantation; people with severe obesity (BMI over 40 kg / m2) and persons over 65 years of age.
  13. https://www.vakcinace.eu/data/files/downloads/ockovaci_kalendar_dospsdatem.pdf
  14. https://www.ssi.dk/vaccinationer/risikogrupper/personer-over-65-ar
  15. https://www.vaktsineeri.ee/en/node/168 Payment for vaccination Adults can be vaccinated against diphtheria and tetanus free of charge (protection must be renewed every 10 years).The state also covers the costs of vaccination in the event of an outbreak of measles (for the sick or exposed). Other vaccines are chargeable.
  16. https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/pneumococcal-vaccines
  17. For individuals from 5 years with increased risk of invasive pneumococcal disease. the scheme is based upon history of vaccination with PCV vaccines. if not previously vaccinated: PCV13 then PPSV23 (at least 8 weeks in between). If previous vaccination with PPSV23 >one year: PCV13 then PPSV23 (at least 5 years after initial PPSV23). If previously vaccinated with PCV13+PPSV23: further PPSV23 at least 5 years after the last dose.
  18. number of doses necessary varies according to age
  19. https://edoc.rki.de/bitstream/handle/176904/2961/23tLoXFfwIoxE.pdf?sequence=1&isAllowed=y
  20. PPSV is recommended in addition to PCV13 at least 2 months after the last dose of PCV13 in subjects > 2 years with an increased risk of disease from pneumococcal infections. A booster dose of PPSV23 is recommended 5 years after the first dose
  21. One dose is recommended for all adults over age 60. For risk groups one dose of conjugated vaccine and one dose of PPS vaccine is recommended after 2 years of age . for more information see: https://www.landlaeknir.is/servlet/file/store93/item23265/Lei%C3%B0beiningar%20um%20notkun_b%C3%B3luefna_gegn_pneum%C3%B3kokkum-final.pdf
  22. The vaccine is free of charge, but administration fees may be charged to patient (based on income and eligibility for free healthcare)
  23. one dose of PCV13 at 65 years and one dose PPSV after at least 8 weeks
  24. Can be administered concomitantly with MMR
  25. It is recommended that populations at risk and elderly 65 years of age and over receive a dose of 13-valent pneumococcal conjugate vaccine (PCV13) followed, 8 weeks later, by a dose of 23-valent pneumococcal polysaccharide vaccine (PCV23). In the present state of knowledge, the CSMI recommends a PPV23 recall only in people at risk, who are recalled every 5 years. Children at risk of invasive pneumococcal infection are also affected by this recommendation: in the absence of previous vaccination with PCV13, catch-up is indicated. For mopre informeation: http://www.sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/index.html
  26. Implementation starting from fall 2020. Vaccination recommended for healthy adults aged 60 to 75 years. First dose at 60 years followed by booster doses every 5 years with a last dose at 75 years. More information available at: https://www.rivm.nl/pneumokokken/pneumokokkenvaccinatie-voor-ouderen https://www.rivm.nl/en/pneumococci/information-for-policy-makers
  27. One dose if not vaccinated in the previous 10 years. Reimbursed for some at-risk groups. https://www.fhi.no/nettpub/vaksinasjonsveilederen-for-helsepersonell/vaksiner-mot-de-enkelte-sykdommene/pneumokokkvaksinasjon---veileder-fo/
  28. https://www.dgs.pt/paginas-de-sistema/saude-de-a-a-z/programa-nacional-de-vacinacao/vacinas-do-pnv/infecoes-por-streptococcus-pneumoniae.aspx
  29. Pneumococcal conjugate vaccine will be included in the national vaccination calendar depending on available funds
  30. Recommended to all. Mandatory to persons residing in social care facilities
  31. PCV and PPSV23 recommended, self-paid
  32. For recommendations in children and adults with high risk conditions Please refer to https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/VacGruposRiesgo/docs/VacGruposRiesgo_todas_las_edades.pdf
  33. For recommendations in children and adults with high risk conditions, refer to: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/VacGruposRiesgo/docs/VacGruposRiesgo_todas_las_edades.pdf
  34. Funding varies by region. https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/vacciner-a-o/pneumokocker/